IL17F and palmoplantar pustulosis: In addition to the hyperactivity of the IL-36 pathway, PPP patients also exhibit activation of the IL-17 pathway, with significantly elevated levels of certain cytokines from the IL-17 family (such as IL-17A, IL-17C, IL-17F) in skin tissues (16).